A PTG variant contributes to a milder phenotype in Lafora disease.
Lafora disease is an autosomal recessive form of progressive myoclonus epilepsy with no effective therapy. Although the outcome is always unfavorable, onset of symptoms and progression of the disease may vary. We aimed to identify modifier genes that may contribute to the clinical course of Lafora d...
Guardado en:
Autores principales: | Rosa Guerrero, Santiago Vernia, Raúl Sanz, Irene Abreu-Rodríguez, Carmen Almaraz, María García-Hoyos, Roberto Michelucci, Carlo Alberto Tassinari, Patrizia Riguzzi, Carlo Nobile, Pascual Sanz, José M Serratosa, Pilar Gómez-Garre |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/decbd37294894b3a9ad223c460a37b7c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.
por: Santiago Vernia, et al.
Publicado: (2009) -
An empirical pipeline for personalized diagnosis of Lafora disease mutations
por: M. Kathryn Brewer, et al.
Publicado: (2021) -
Epilepsia de Lafora
por: Núñez D,Carolina, et al.
Publicado: (2008) -
Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity.
por: Vikas V Dukhande, et al.
Publicado: (2011) -
General versus executive cognitive ability in pupils with ADHD and with milder attention problems
por: Ek U, et al.
Publicado: (2013)